Cadila Healthcare receives EIR for Ankleshwar unit

23 Sep 2019 Evaluate

Cadila Healthcare’s API manufacturing facility located at Ankleshwar (Unit 1) in Gujarat has received an Establishment Inspection Report (EIR). The US Food and Drug Administration (USFDA) had conducted an inspection at the facility from July 22 to 26, 2019. The EIR report stated that the classification of the facility is ’No Action Indicated (NAI)’

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

884.85 8.75 (1.00%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×